Pharmaceuticals in the environment-Global occurrences and perspectives

Environmental Toxicology and Chemistry

Volumn 35, Issue 4, 2016, Pages 823-835

  aus der Beek, Tim ^a   Weber, Frank Andreas ^a   Bergmann, Axel ^a   Hickmann, Silke ^b   Ebert, Ina ^b   Hein, Arne ^b   Küster, Anette ^b  

^a IWW Water Centre   (Germany)

^b Section IV 22 Pharmaceuticals   (Germany)

Author keywords

Emerging pollutant; Global measured environmental concentration database; Measured environmental concentration; Pharmaceutical; Pharmaceutical consumption

Indexed keywords

DATABASE SYSTEMS; DEVELOPING COUNTRIES; DRUG PRODUCTS; FERTILIZERS; GROUNDWATER; INDUSTRIAL EMISSIONS; MATRIX ALGEBRA;

ANTI-INFLAMMATORY DRUGS; EMERGING POLLUTANTS; ENVIRONMENTAL CONCENTRATION; INDUSTRIALIZED COUNTRIES; MULTI-STAKEHOLDER APPROACH; PREDICTED NO-EFFECT CONCENTRATIONS; TRANSFORMATION PRODUCTS; VETERINARY PHARMACEUTICALS;

SURFACE WATERS;

ACETYLSALICYLIC ACID; AMOXICILLIN; AZITHROMYCIN; CARBAMAZEPINE; CIPROFLOXACIN; CLARITHROMYCIN; CLOFIBRIC ACID; DICLOFENAC; DRINKING WATER; ERYTHROMYCIN; ESTRADIOL; ESTRIOL; ESTROGEN; ESTRONE; ETHINYLESTRADIOL; GROUND WATER; IBUPROFEN; NAPROXEN; NORFLOXACIN; OFLOXACIN; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PIRLIMYCIN; SULFAMETHOXAZOLE; SURFACE WATER; TAP WATER; TRIMETHOPRIM; UNINDEXED DRUG; VANCOMYCIN; VETERINARY DRUG; DRUG; POLLUTANT; WASTE WATER; WATER POLLUTANT;

CONCENTRATION (COMPOSITION); DATA QUALITY; DATABASE; DEVELOPING WORLD; DRUG; EMISSION; ENVIRONMENTAL ASSESSMENT; ENVIRONMENTAL MONITORING; GLOBAL PERSPECTIVE; HETEROGENEITY; LITERATURE REVIEW; STAKEHOLDER; UNITED NATIONS ENVIRONMENT PROGRAM; URBAN AREA; WASTEWATER;

AGRICULTURE; AQUACULTURE; ARTICLE; CONCENTRATION (PARAMETERS); DATA BASE; DEVELOPING COUNTRY; ENVIRONMENTAL MONITORING; GEOGRAPHIC DISTRIBUTION; HOSPITAL; INDUSTRIAL PRODUCTION; INDUSTRIALIZATION; LIMIT OF DETECTION; PRIORITY JOURNAL; QUALITY CONTROL; SEWAGE; UNITED NATIONS; URBAN AREA; WASTE WATER; WATER CONTAMINATION; ANALYSIS; ANIMAL; CHEMISTRY; HUMAN; POLLUTANT; WATER POLLUTANT;

AGRICULTURE; ANIMALS; AQUACULTURE; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; HOSPITALS; HUMANS; PHARMACEUTICAL PREPARATIONS; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84977830639     PISSN: 07307268     EISSN: 15528618     Source Type: Journal    
DOI: 10.1002/etc.3339     Document Type: Article

References (59)

1. Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, Laxminarayan R. 2014. Global antibiotic consumption 2000 to 2010: An analysis of national pharmaceutical sales data. Lancet Infect Dis 14:742-750.
2. Zrnčić M, Gros M, Babić S, Kaštelan-Macan M, Barcelo D, Petrović M. 2014. Analysis of anthelmintics in surface water by ultra high performance liquid chromatography coupled to quadrupole linear ion trap tandem mass spectrometry. Chemosphere 99:224-232.
3. Boxall ABA, Rudd MA, Brooks BW, Caldwell DJ, Choi K, Hickmann S, Innes E, Ostapyk K, Staveley JP, Verslycke T, Ankley GT, Beazley KF, Belanger SE, Berninger JP, Carriquiriborde P, Coors A, DeLeo PC, Dyer SD, Ericson JF, Gagné F, Giesy JP, Gouin T, Hallstrom L, Karlsson MV, Larsson DGJ, Lazorchak JM, Mastrocco F, McLaughlin A, McMaster ME, Meyerhoff RD, Moore R, Parrott JL, Snape JR, Murray-Smith R, Servos MR Sibley PK, Straub JO, Szabo ND, Topp E, Tetreault GR, Trudeau VL, Van Der Kraak G. 2012. Pharmaceuticals and personal care products in the environment: What are the big questions? Environ Health Perspect 120:9.
4. Triebskorn R, Casper H, Scheil V, Schwaiger J. 2007. Ultrastructural effects of pharmaceuticals (carbamazepine, clofibric acid, metoprolol, diclofenac) in rainbow trout (Oncorhynchus mykiss) and common carp (Cyprinus carpio). Anal Bioanal Chem 387:1405-1416.
5. Foster HR, Burton GA, Basu N, Werner EE. 2010. Chronic exposure to fluoxetine (Prozac) causes developmental delays in Rana pipiens larvae. Environ Toxicol Chem 29:2845-2850.
6. Brodin T, Fick J, Johnsson M, Klaminder J. 2013. Dilute concentrations of a psychiatric drug alter behaviour of fish from natural populations. Science 339:418-815.
7. Ebert I, Bachmann J, Kühnen U, Küster A, Kussatz C, Maletzki D, Schlüter C. 2011. Toxicity of the fluoroquinolone antibiotics enrofloxacin and ciprofloxacin to photoautotrophic aquatic organisms. Environ Toxicol Chem 30:2786-2792.
8. Kidd KA, Mills KH, Palace VP, Evans RE, Lazorchak JM, Flick RW. 2007. Collapse of a fish population after exposure to synthetic estrogen. Proc Natl Acad Sci USA 104:8897-8901.
9. Michelini LA, Reichel RB, Werner WC, Ghisi RA, Thiele-Bruhn S. 2012. Sulfadiazine uptake and effects on Salix fragilis l. and Zea mays l. plants. Water Air Soil Pollut 223:5243-5257.
10. Liebig M, Fernandez AA, Blübaum-Gronau E, Boxall A, Brinke M, Carbonell G, Egeler P, Fenner K, Fernandez C, Fink G, Garric J, Halling-Sørensen B, Knacker T, Krogh KA, Küster A, Löffler D, Ángel M, Cots P, Pope L, Prasse C, Römbke J, Rönnefahrt I, Schneider MK, Schweitzer N, Tarazona JV, Ternes TA, Traunspurger W, Wehrhan A, Duisy K. 2010. Environmental risk assessment of ivermectin: A case study. Integr Environ Assess Manage 6:567-587.
11. Oaks JL, Gilbert M, Virani MZ, Watson RT, Meteyer CU, Rideout BA, Shivaprasad HL, Ahmed S, Chaudry MJI, Arshad M, Mahmood S, Ali A, Khan AA. 2004. Diclofenac residues as the cause of population decline of vultures in Pakistan. Nature 427:630-633.
12. Strategic Approach to International Chemicals Management. 2014. New proposed emerging policy issue: Environmentally persistent pharmaceutical pollutants. Note by the secretariat. Open-ended Working Group of the International Conference on Chemicals Management Second meeting Geneva, Switzerland, 15-17 December 2014. [cited 2015 January 26]. Available from: http://www.saicm.org/images/saicm_documents/OEWG2/Meetingdocs/FINAL/Doc7/k1402765%20saicm-eowg2-7-e.pdf
13. Bu Q, Wang B, Huang J, Deng S, Yu G. 2013. Pharmaceuticals and personal care products in the aquatic environment in China: A review. J Hazard Mater 262:189-211.
14. Falås P, Andersen HR, Ledin A, la Cour Jansen J. 2012. Occurrence and reduction of pharmaceuticals in the water phase at Swedish wastewater treatment plants. Water Sci Technol 66:783-791.
15. González S, López-Roldán R, Cortina J-L. 2012. Presence and biological effects of emerging contaminants in Llobregat River basin: A review. Environ Pollut 161:83-92.
16. Klečka G, Persoon C, Currie R. 2010. Chemicals of emerging concern in the Great Lakes basin: An analysis of environmental exposures. In Whitacre DM, ed, Reviews of Environmental Contamination and Toxicology, Vol 207. Springer, New York, NY, USA, pp 1-93.
17. Calisto V, Esteves VI. 2009. Psychiatric pharmaceuticals in the environment. Chemosphere 77:1257-1274.
18. Besse J-P, Latour J-F, Garric J. 2012. Anticancer drugs in surface waters: What can we say about the occurrence and environmental significance of cytotoxic, cytostatic and endocrine therapy drugs? Environ Int 39:73-86.
19. Daghrir R, Drogui P. 2013. Tetracycline antibiotics in the environment: A review. Environ Chem Lett 11:209-227.
20. Kemper N. 2008. Veterinary antibiotics in the aquatic and terrestrial environment. Ecol Indic 8:1-13.
21. Aguayo S, Torre ADL, Carballo M, Cabrera R, Méndez J. 2010. A review of the most relevant residues of pharmaceuticals products of human use in effluents and sludges from waste water treatment plants. Toxicol Lett 196:S65.
22. Lapworth DJ, Baran N, Stuart ME, Ward RS. 2012. Emerging organic contaminants in groundwater: A review of sources, fate and occurrence. Environ Pollut 163:287-303.
23. Petrovic M, Hernando MD, Diaz-Cruz MS, Barcelo D. 2005. Liquid chromatography-tandem mass spectrometry for the analysis of pharmaceutical residues in environmental samples: A review. J Chromatogr A 1067:1-14.
24. Buchberger WW. 2011. Current approaches to trace analysis of pharmaceuticals and personal care products in the environment. J Chromatogr A 1218:603-618.
25. Cardoso O, Porcher J-M, Sanchez W. 2014. Factory-discharged pharmaceuticals could be a relevant source of aquatic environment contamination: Review of evidence and need for knowledge. Chemosphere 115:20-30.
26. Fick J, Söderström H, Lindberg R, Phan C, Tysklind M, Larsson J. 2009. Contamination of surface, ground, and drinking water from pharmaceutical production. Environ Toxicol Chem 28:2522-2527.
27. Orias F, Perrodin Y. 2013. Characterisation of the ecotoxicity of hospital effluents: A review. Sci Total Environ 454-455:250-276.
28. Fatta-Kassinos D, Vasquez MI, Kümmerer K. 2011. Transformation products of pharmaceuticals in surface waters and wastewater formed during photolysis and advanced oxidation processes-Degradation, elucidation of byproducts and assessment of their biological potency. Chemosphere 85:693-709.
29. Miège C, Choubert JM, Ribeiro L, Eusèbe M, Coquery M. 2009. Fate of pharmaceuticals and personal care products in wastewater treatment plants-Conception of a database and first results. Environ Pollut 157:1721-1726.
30. Li WC. 2014. Occurrence, sources, and fate of pharmaceuticals in aquatic environment and soil. Environ Pollut 187:193-201.
31. Hughes SR, Kay P, Brown LE. 2012. Global synthesis and critical evaluation of pharmaceutical data sets collected from river systems. Environ Sci Technol 47:661-677.
32. Sadezky A, Löffler D, Ternes T. 2008. KNAPPE (Knowledge and Need Assessment on Pharmaceutical Products in Environmental Waters)-Deliverable number: D1. 2: Proposal of an environmental indicator and classification system of pharmaceutical product residues for environmental management. German Federal Institute of Hydrology, Koblenz, Germany.
33. Joint Research Center. 2012. FATE SEES-Results of a pan-European snapshot of randomly taken sewage sludge sample. [cited 2014 December 11]. Available from: http://ec.europa.eu/environment/archives/waste/sludge/pdf/FATE_SEES_pres.pdf
34. Ternes T, Janex-Habibi M-L, Knacker T, Kreuzinger N, Siegrist H. 2004. Assessment of technologies for the removal of pharmaceuticals and personal care products in sewage and drinking water facilities to improve the indirect potable water reuse. [cited 2014 December 11]. Available from: http://ec.europa.eu/research/endocrine/pdf/poseidon_final_report_summary_en.pdf
35. Bergmann A, Fohrmann R, Weber F-A. 2011. Zusammenstellung von Monitoringdaten zu Umweltkonzentrationen von Arzneimitteln. UBA Texte 66. Umweltbundesamt, Dessau, Germany. [cited 2015 January 26]. Available from: http://www.umweltbundesamt.de/sites/default/files/medien/461/publikationen/4188.pdf
36. Hamscher G, Pawelzick HT, Sczesny S, Nau H, Hartung J. 2003. Antibiotics in dust originating from a pig-fattening farm: A new source of health hazard for farmers? Environ Health Perspect 111:1590-1594.
37. de Jager C, Swemmer A, Aneck-Hahn NH, van Zijl C, van Wyk S, Bornman MS, Barnhoorn I, Jonker M, van Vuren JHJ, Burger AEC. 2011. Endocrine disrupting chemical (EDC) activity and health effects of identified veterinary growth stimulants in surface and groundwater. Water Research Commission South Africa, Pretoria, South Africa.
38. K'Oreje KO, Demeestere K, De Wispelaere P, Vergeynst L, Dewulf J, Van Langenhove H. 2012. From multi-residue screening to target analysis of pharmaceuticals in water: Development of a new approach based on magnetic sector mass spectrometry and application in the Nairobi River basin, Kenya. Sci Total Environ 437:153-164.
39. Bruchet A, Hochereau C, Picard C, Decottignies V, Rodrigues JM, Janex-Habibi ML. 2005. Analysis of drugs and personal care products in French source and drinking waters: The analytical challenge and examples of application. Water Sci Technol 52:53-61.
40. World Health Organization. 2012. Pharmaceuticals in drinking water. Geneva, Switzerland.
41. United Nations. 2013. World contraceptive patterns 2013. ST/ESA/SER.A/326. New York, NY, USA. [cited 2014 December 11]. Available from: http://www.un.org/en/development/desa/population/publications/pdf/family/worldContraceptivePatternsWallChart2013.pdf
42. Camacho-Muñoz D, Martín J, Santos JL, Aparicio I, Alonso E. 2010. Occurrence, temporal evolution and risk assessment of pharmaceutically active compounds in Doñana Park (Spain). J Hazard Mater 183:602-608.
43. Larsson DGJ. 2014. Pollution from drug manufacturing: Review and perspectives. Philos Trans R Soc B 369:20130571.
44. Dolar D, Zokic TI, Kosutic K, Asperger D, Pavlovic DM. 2012. RO/NF membrane treatment of veterinary pharmaceutical wastewater: Comparison of results obtained on a laboratory and a pilot scale. Environ Sci Pollut Res 19:1033-1042.
45. Shimizu A, Takada H, Koike T, Takeshita A, Saha M, Rinawati, Nakada N, Murata A, Suzuki T, Suzuki S, Chiem NH, Tuyen BC, Viet PH, Siringan MA, Kwan C, Zakaria MP, Reungsang A. 2013. Ubiquitous occurrence of sulfonamides in tropical Asian waters. Sci Total Environ 452-453:108-115.
46. Weber F-A, Beek Tad, Bergmann A. 2014. Analytics of environmental samples from Nigeria with respect to relevant pharmaceutical substances. UFORDAT (UBA-FB 002027/E). Umweltbundesamt, Dessau, Germany.
47. Kookana RS, Williams M, Boxall ABA, Larsson DGJ, Gaw S, Choi K, Yamamoto H, Thatikonda S, Zhu Y-G, Carriquiriborde P. 2014. Potential ecological footprints of active pharmaceutical ingredients: An examination of risk factors in low-, middle- and high-income countries. Philos Trans R Soc B 369:20130586.
48. Chefetz B, Goldstein M, Malchi T, Yakir R, Colon de Mello E, Grossberger A, Tadmor G, Shenker M, Hadar Y. 2013. Crop irrigation with treated wastewater: Uptake of pharmaceuticals by crops, fate and processes in arable soils. Workshop: Pharmaceuticals in Soil, Sludge and Slurry. Dessau, Germany, June 2013.
49. Fent K, Weston AA, Caminada D. 2006. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76:122-159.
50. Triebskorn R, Schwarz S, Köhler H-R, Berg K, Jungmann D, Frey M, Oehlmann J, Oetken M. 2014. From theory to reality-Evaluation of suitable organisms and test systems for the biomonitoring of pharmaceuticals. Part I: Literature review. UBA-Texte 64/2014. [cited 2015 January 26]. Available from: http://www.umweltbundesamt.de/sites/default/files/medien/378/publikationen/texte_64_2014_from_theory_to_reality_biomonitoring_pharmaceuticals.pdf
51. European Commission. 2013. Diclofenac EQS dossier. [cited 2015 January 26]. Available from: https://circabc.europa.eu/sd/a/d88900c0-68ef-4d34-8bb1-baa9af220afd/Diclofenac%20EQS%20dossier%202011.pdf
52. Harris CA, Hamilton PB, Runnalls TJ, Vinciotti V, Henshaw A, Hodgson D, Coe TS, Jobling S, Tyler CR, Sumpter JP. 2011. The consequences of feminization in breeding groups of wild fish. Environ Health Perspect 119:306-311.
53. Caldwell DJ, Mastrocco F, Anderson PD, Länge R, Sumpter JP. 2012. Predicted-no-effect concentrations for the steroid estrogens estrone, 17β-estradiol, estriol, and 17α-ethinylestradiol. Environ Toxicol Chem 31:1396-1406.
54. European Commission. 2001. Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products. [cited 2015 January 26]. Available from: http://ec.europa.eu/health/files/eudralex/vol-5/dir_2001_82/dir_2001_82_en.pdf
55. European Commission. 2001. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. [cited 2015 January 26]. Available from: http://ec.europa.eu/health/files/eudralex/vol-1/dir_2001_83_consol_2012/dir_2001_83_cons_2012_en.pdf
56. Küster A, Adler N. 2014. Pharmaceuticals in the environment: Scientific evidence of risks and its regulation. Philos Trans R Soc B 369:20130587.
57. Daughton CG. 2014. The Matthew effect and widely prescribed pharmaceuticals lacking environmental monitoring: Case study of an exposure-assessment vulnerability. Sci Total Environ 466-467:315-325.
58. World Health Organization Collaborating Centre for Drug Statistics Methodology. 2014. ATC classification index with defined daily doses. Oslo, Norway.
59. International Institute for Sustainable Development. 2015. Earth Negotiations Bulletin. Fourth session of the International Conference on Chemicals Management, Geneva, Switzerland, September 28-October 2, 2015.